NYSE · Healthcare · Drug Manufacturers - General
Price at previous close. Open the live page for real-time data.
| Market cap | $294.03B |
| P/E ratio | 32.937144459988815 |
| P/B ratio | 6.414695186145864 |
| P/S ratio | 4.482682551583248 |
| Dividend yield | 2.82% |
| Return on equity | — |
| Net margin | 13.6% |
| EPS (TTM) | — |
| Beta | 0.218 |
| 52-week range | $76.66 – $125.14 |
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies…
What is Merck & Co., Inc.'s P/E ratio?
Merck & Co., Inc.'s trailing price-to-earnings (P/E) ratio is 32.9.
Does Merck & Co., Inc. pay a dividend?
Yes — the trailing dividend yield is approximately 2.82%.
What is MRK's market capitalisation?
Merck & Co., Inc.'s market cap is approximately $294.03B.
Educational data only — not financial advice. Figures from Financial Modeling Prep, updated periodically. Verify before acting.